financetom
Business
financetom
/
Business
/
Otter Tail Insider Sold Shares Worth $354,960, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Otter Tail Insider Sold Shares Worth $354,960, According to a Recent SEC Filing
Aug 14, 2024 9:44 AM

12:17 PM EDT, 08/14/2024 (MT Newswires) -- Jennifer O. Smestad, Vice President, General Council & Corporate Secretary, on August 13, 2024, sold 4,000 shares in Otter Tail (OTTR) for $354,960. Following the Form 4 filing with the SEC, Smestad has control over a total of 12,839 shares of the company, with 12,300 shares held directly and 539 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1466593/000146659324000131/xslF345X03/wk-form4_1723651947.xml

Price: 87.61, Change: -1.65, Percent Change: -1.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Law firm Boies Schiller denies hedge fund collusion in home buyer class action
Law firm Boies Schiller denies hedge fund collusion in home buyer class action
Oct 17, 2024
Oct 14 (Reuters) - Law firm Boies Schiller Flexner is pushing back against litigation misconduct claims in a proposed class action against United Wholesale Mortgage, hoping to derail the home lending giant's bid to dismiss the case and recoup legal fees. The six-month-old lawsuit alleged that UWM conspired with brokers to force home buyers into expensive mortgages and pocketed billions...
What Happened With Invo BioScience Stock Today?
What Happened With Invo BioScience Stock Today?
Oct 17, 2024
INVO BioScience, Inc. ( INVO ) shares soared Monday after the company announced it closed its merger with NAYA Biosciences.  The Details: Invo BioScience ( INVO ) said the combined company will continue to operate its fertility business as well as expand its focus to the development of clinical-stage assets in oncology and autoimmune diseases. The company expects to change...
Helius Medical to Challenge Medicare Reimbursement Decision for Neuromodulation Stimulator Mouthpiece
Helius Medical to Challenge Medicare Reimbursement Decision for Neuromodulation Stimulator Mouthpiece
Oct 17, 2024
06:02 PM EDT, 10/14/2024 (MT Newswires) -- Helius Medical Technologies ( HSDT ) said Monday that it will challenge the Centers for Medicare & Medicaid Services' decision to finalize a $2,963.30 reimbursement for its portable neuromodulation stimulator mouthpiece, effective Jan. 1. The new reimbursement determination corrects Medicare's initial decision of monthly rental payments, Helius added. Medicare deferred its decision on...
Spectral AI Names Founder Michael DiMaio as Chair; CEO Leaves
Spectral AI Names Founder Michael DiMaio as Chair; CEO Leaves
Oct 17, 2024
05:35 PM EDT, 10/14/2024 (MT Newswires) -- Spectral AI (MDAI) has named founder J. Michael DiMaio as board chairman, the company said Monday. The office of the chairman has been set up to oversee day-to-day operations, according to the company. As part of the transition, CEO Peter Carlson will be leaving his position at the company, but will remain as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved